GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
39.92 -0.13  -0.32% NYSE Sep 19, 20:00 Delayed 2m USD

GlaxoSmithKline Free Cash Flow (Quarterly):

535.18M for June 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

GlaxoSmithKline Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2017 535.18M
March 31, 2017 901.66M
Dec. 31, 2016 3.101B
Sept. 30, 2016 1.592B
June 30, 2016 1.090B
March 31, 2016 -166.06M
Dec. 31, 2015 1.261B
Sept. 30, 2015 55.44M
June 30, 2015 -303.21M
March 31, 2015 7.579M
Dec. 31, 2014 2.639B
Sept. 30, 2014 1.408B
June 30, 2014 642.38M
March 31, 2014 956.35M
Dec. 31, 2013 2.693B
Sept. 30, 2013 2.541B
June 30, 2013 1.959B
March 31, 2013 1.445B
Dec. 31, 2012 2.212B
Sept. 30, 2012 -1.068B
June 30, 2012 2.191B
March 31, 2012 1.189B
Dec. 31, 2011 2.674B
Sept. 30, 2011 2.445B
June 30, 2011 1.623B
   
March 31, 2011 1.150B
Dec. 31, 2010 1.540B
Sept. 30, 2010 1.102B
June 30, 2010 2.515B
March 31, 2010 2.801B
Dec. 31, 2009 2.216B
Sept. 30, 2009 3.016B
June 30, 2009 2.178B
March 31, 2009 1.937B
Dec. 31, 2008 2.347B
Sept. 30, 2008 2.433B
June 30, 2008 1.780B
March 31, 2008 2.939B
Dec. 31, 2007 1.492B
Sept. 30, 2007 2.932B
June 30, 2007 1.979B
March 31, 2007 1.646B
Dec. 31, 2006 1.724B
Sept. 30, 2006 -821.97M
June 30, 2006 1.483B
March 31, 2006 2.716B
Dec. 31, 2005 1.346B
Sept. 30, 2005 2.994B
June 30, 2005 2.154B
March 31, 2005 2.195B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Free Cash Flow

Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More

Advertisement

GSK Free Cash Flow (Quarterly) Benchmarks

Companies
Johnson & Johnson 5.083B
Eli Lilly 1.430B
Merck & Co 2.924B

GSK Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum -1.068B Sep 2012
Maximum 3.101B Dec 2016
Average 1.175B

GSK Free Cash Flow (Quarterly) Excel Add-In Codes

  • Metric Code: free_cash_flow
  • Latest data point: =YCP("GSK", "free_cash_flow")
  • Last 5 data points: =YCS("GSK", "free_cash_flow", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.